158 related articles for article (PubMed ID: 19169862)
21. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.
Kim DY; Kim JG; Kim YJ; Joe SG; Lee JY
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7040-6. PubMed ID: 25298415
[TBL] [Abstract][Full Text] [Related]
22. Hemostatic effects of SF6 after diabetic vitrectomy for vitreous hemorrhage.
Koutsandrea CN; Apostolopoulos MN; Chatzoulis DZ; Parikakis EA; Theodossiadis GP
Acta Ophthalmol Scand; 2001 Feb; 79(1):34-8. PubMed ID: 11167284
[TBL] [Abstract][Full Text] [Related]
23. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
Lee DY; Jeong HS; Sohn HJ; Nam DH
Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (Observational Study).
Liang X; Zhang Y; Wang JX; Wang LF; Huang WR; Tang X
Medicine (Baltimore); 2019 May; 98(20):e15735. PubMed ID: 31096535
[TBL] [Abstract][Full Text] [Related]
25. Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage?
Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
Eur J Ophthalmol; 2009; 19(4):618-21. PubMed ID: 19551678
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of the Cochrane Review: Anti-vascular Endothelial Growth Factor for Prevention of Postoperative Vitreous Cavity Hemorrhage after Vitrectomy for Proliferative Diabetic Retinopathy. Cochrane Database Syst Rev. 2015;8:CD008214.].
Sousa DC; Leal I; Costa J; Vaz-Carneiro A
Acta Med Port; 2017 Aug; 30(7-8):513-516. PubMed ID: 28926323
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.
Modarres M; Nazari H; Falavarjani KG; Naseripour M; Hashemi M; Parvaresh MM
Eur J Ophthalmol; 2009; 19(5):848-52. PubMed ID: 19787608
[TBL] [Abstract][Full Text] [Related]
28. Photocoagulation Up to Ora Serrata in Diabetic Vitrectomy to Prevent Recurrent Vitreous Hemorrhage.
Yoon CY; Shin MC; Kim P; Shin YK; Kim WJ
Korean J Ophthalmol; 2023 Dec; 37(6):477-484. PubMed ID: 37899285
[TBL] [Abstract][Full Text] [Related]
29. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH; Chen MS
Am J Ophthalmol; 2008 Aug; 146(2):211-217. PubMed ID: 18547539
[TBL] [Abstract][Full Text] [Related]
30. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
[TBL] [Abstract][Full Text] [Related]
31. [Efficiency of air tamponade in prevention of early recurrence of vitreal hemorrhage in diabetic patients with vitrectomy].
Brănişteanu D; Danielescu C; Irimia A; Robu M
Oftalmologia; 2006; 50(2):62-7. PubMed ID: 16927761
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
Yeh PT; Yang CH; Yang CM
Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
34. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
[TBL] [Abstract][Full Text] [Related]
35. Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.
Wang Q; Zhao J; Xu Q; Han C; Hou B; Huang Y
BMC Ophthalmol; 2021 Mar; 21(1):129. PubMed ID: 33750339
[TBL] [Abstract][Full Text] [Related]
36. [Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].
Muramatsu M; Yokoi M; Muramatsu A; Saito W; Furudate N; Ohno S
Nippon Ganka Gakkai Zasshi; 2006 Dec; 110(12):950-60. PubMed ID: 17228758
[TBL] [Abstract][Full Text] [Related]
37. [Influence of membrane dissection and en bloc excision on the outcome of vitreous surgery in proliferative diabetic retinopathy].
Li XX; Jiang YR; Yin H; Zhao MW
Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):439-42. PubMed ID: 15454056
[TBL] [Abstract][Full Text] [Related]
38. Hemostatic effects of air versus fluid in diabetic vitrectomy.
Joondeph BC; Blankenship GW
Ophthalmology; 1989 Dec; 96(12):1701-6; discussion 1706-7. PubMed ID: 2695874
[TBL] [Abstract][Full Text] [Related]
39. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.
Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S
Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948
[TBL] [Abstract][Full Text] [Related]
40. Vitrectomy in diabetic patients with a blind fellow eye.
Bodanowitz S; Hesse L; Weinand F; Kroll P
Acta Ophthalmol Scand; 1996 Feb; 74(1):84-8. PubMed ID: 8689491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]